Health and Quality of Life Outcomes | |
Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: A systematic review of the literature | |
Research | |
Peter M ten Klooster1  Erik Taal1  Martijn AH Oude Voshaar1  Mart AFJ van de Laar2  | |
[1] Department of Psychology, Health and Technology, Arthritis Center Twente, University of Twente, Enschede, The Netherlands;Department of Psychology, Health and Technology, Arthritis Center Twente, University of Twente, Enschede, The Netherlands;Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands; | |
关键词: Physical function; disability; rheumatoid arthritis; psychometric; validity; reliability; responsiveness; measurement properties; | |
DOI : 10.1186/1477-7525-9-99 | |
received in 2011-07-25, accepted in 2011-11-07, 发布年份 2011 | |
来源: Springer | |
【 摘 要 】
BackgroundThe aim of this study was to systematically review the content validity and measurement properties of all physical function (PF) scales which are currently validated for use with patients with rheumatoid arthritis (RA).MethodsSystematic literature searches were performed in the Scopus and PubMed databases to identify articles on the development or psychometric evaluation of PF scales for patients with RA. The content validity of included scales was evaluated by linking their items to the International Classification of Functioning Disability and Health (ICF). Furthermore, available evidence of the reliability, validity, responsiveness, and interpretability of the included scales was rated according to published quality criteria.ResultsThe search identified 26 questionnaires with PF scales. Ten questionnaires were rated to have adequate content validity. Construct validity, internal consistency, test-retest reliability and responsiveness was rated favourably for respectively 15, 11, 5, and 6 of the investigated scales. Information about the absolute measurement error and minimal important change scores were rarely reported.ConclusionBased on this literature review, the disease-specificHAQ and the generic SF-36 can currently be most confidently recommended to measure PF in RA for most research purposes. The HAQ, however, was frequently associated with considerable ceiling effects while the SF-36 has limited content coverage. Alternative scales that might be better suited for specific research purposes are identified along with future directions for research.
【 授权许可】
CC BY
© Oude Voshaar et al; licensee BioMed Central Ltd. 2011
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311106321432ZK.pdf | 492KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
- [56]
- [57]
- [58]
- [59]
- [60]
- [61]
- [62]
- [63]
- [64]
- [65]
- [66]
- [67]
- [68]
- [69]
- [70]
- [71]
- [72]
- [73]
- [74]
- [75]
- [76]
- [77]
- [78]
- [79]
- [80]
- [81]
- [82]
- [83]
- [84]
- [85]
- [86]
- [87]
- [88]
- [89]
- [90]
- [91]
- [92]
- [93]
- [94]
- [95]
- [96]
- [97]
- [98]
- [99]
- [100]